Home > Legal Library > Advanced Search > Search Results









Join Matindale-Hubbell Connected



Search Results (1513)

  
Documents on Litigation, Pharmaceuticals, Health Care
 

View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLProduction Order Challenge Results in Recognition of Duty to Assert Consumer Privacy Rights
Bonnie Freedman, Graeme Hamilton; Borden Ladner Gervais LLP;
Legal Alert/Article
January 28, 2016, previously published on January 19, 2016
On January 14th, 2016, in R. v. Rogers Communications, Sproat J. of the Superior Court of Justice issued a very important decision for organizations that find themselves subject to a search warrant or production order seeking personal information in their records about third parties. The Court...

 

HTMLDecisions re Motions to Strike Upheld: Agreement with Ratiopharm Does Not Preclude Teva Section 8 Claim
Adrian J. Howard, Beverley Moore, Chantal Saunders; Borden Ladner Gervais LLP;
Legal Alert/Article
January 5, 2016, previously published on December 17, 2015
The Pfizer appellants (Pfizer) appealed the decision of the Court denying their motion for summary judgment in respect of the action by Teva Canada Limited (Teva) pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations (Regulations). The issue in Pfizer's motion related...

 

HTMLClass Action Certification against Pfizer for an Allegation of Unlawful Abuse of the Patent System is Overturned
Adrian J. Howard, Beverley Moore, Chantal Saunders; Borden Ladner Gervais LLP;
Legal Alert/Article
January 5, 2016, previously published on December 17, 2015
The British Columbia Court of Appeal has overturned the certification of a class action relating to the drug Viagra, dismissing the action.

 

HTMLUpdate on Bill 122: Amendments to the Mental Health Act and Health Care Consent Act
Barbara Walker-Renshaw; Borden Ladner Gervais LLP;
Legal Alert/Article
January 5, 2016, previously published on December 18, 2015
Bill 122 passed third reading and received Royal Assent on December 10, 2015. The amended legislation comes into force on December 21, 2015. The amendments affect practice and procedure at Ontario's Schedule 1 psychiatric facilities as they relate to the management of long-term involuntarily...

 

Adobe PDFPublic Disclosure of Private Facts: Recent Privacy Law Decisions
Larry P. Reimer, Laina Smith; Blaney McMurtry LLP;
Legal Alert/Article
October 20, 2015, previously published on October 5, 2015
In 2012 the Ontario Court of Appeal was presented, in the case of Jones v. Tsige, with a stark question: Does the common law of Ontario recognize a right to a civil action for damages for invasion of personal privacy?1

 

HTMLAmarin and Off-Label Drug Use: What it Means for the Pharmaceutical Industry
Stephen G. Sozio; Jones Day;
Legal Alert/Article
September 14, 2015, previously published on September 2015
The U.S. District Court for the Southern District of New York recently issued a significant decision in Amarin Pharma, Inc. et al v. United States Food & Drug Administration. Amarin sought and won a preliminary injunction against the FDA to stop it from pursuing a misbranding case against the...

 

HTMLDOJ Issues Memo Directing Prosecutors to Focus on Individual Accountability
Mintz Levin Cohn Ferris Glovsky Popeo P.C.;
Legal Alert/Article
September 14, 2015, previously published on September 11, 2015
The U.S. Department of Justice (DOJ) issued a memorandum on Wednesday from Deputy Attorney General Sally Quillian Yates that reaffirms the Government’s commitment to prosecuting individuals and formally instructs prosecutors to focus on individual accountability when dealing with corporate...

 

HTMLU.S. District Court Issues Ruling on Preliminary Motion to Dismiss Interpreting 60-Day Overpayment Rule: Holds Identification Occurs when Providers Are "Put on Notice" of Potential Overpayment
Lindsey Lonergan, Rebekah N. Plowman; Jones Day;
Legal Alert/Article
September 10, 2015, previously published on September 2015
Compliance with the labyrinth of health care rules and regulations has always been a burdensome challenge for health care providers, and particularly for compliance officers who are frequently presented with potential overpayments that after months of investigation fail to reveal an actual...

 

HTMLCON Laws, COPAs and the FTC: 7 Antitrust Points for the Healthcare Sector
Steven Levitsky, Lesli C. sposito; DLA Piper (Canada) LLP;
Legal Alert/Article
September 10, 2015, previously published on August 6, 2015
The Federal Trade Commission is on a roll in its attack on what it considers anti-competitive effects in the healthcare industry. And that roll has consistently involved challenging activity that once appeared to be protected by state laws.

 

HTMLFDA Updates List of Tropical Diseases Eligible for Award of Priority Review Voucher
Edgar J. Asebey, Maureen Bennett, Christian B. Fulda, Colleen Heisey, Cristiana Spontoni; Jones Day;
Legal Alert/Article
September 4, 2015, previously published on September 2015
In a final order issued August 20, 2015, FDA updated the list of tropical disease products eligible to receive a priority review voucher ("PRV"), an incentive to encourage the development of new drugs for the prevention or treatment of certain diseases by providing priority review of a...

 


View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>